Search
News
Downloads
About
Help
Contact
Entity Details
Primary name
GCNT1
Entity type
gene
Source
Source Link
Details
PrimaryID
2650
RefseqGene
Symbol
GCNT1
Name
glucosaminyl (N-acetyl) transferase 1
Chromosome
9
Location
9q21.13
TaxID
9606
Status
live
SourceGenome
genomic
SourceOrigin
natural
CreationDate
1998-08-17
ModificationDate
2021-06-11
Ontological Relatives
UniProt IDs
GCNT1_HUMAN
GO terms
Show/Hide Table
GO
Name
GO:0000139
Golgi membrane
GO:0003829
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity
GO:0005615
extracellular space
GO:0005802
trans-Golgi network
GO:0008375
acetylglucosaminyltransferase activity
GO:0009101
glycoprotein biosynthetic process
GO:0016021
integral component of membrane
GO:0016266
O-glycan processing
GO:0031985
Golgi cisterna
GO:0032868
response to insulin
GO:0048729
tissue morphogenesis
GO:0050901
leukocyte tethering or rolling
GO:0060352
cell adhesion molecule production
GO:0060993
kidney morphogenesis
Diseases
Show/Hide Table
Interactions
22 interactions
Interactor
Partner
Sources
Publications
Link
GCNT1
GOLPH3
UniProt
23027862
details
GCNT1
CCT7
UniProt
23027862
details
GCNT1
RSU1
UniProt
23027862
details
GCNT1
VPS36
UniProt
23027862
details
GCNT1
OSBPL1A
UniProt
23027862
details
GCNT1
CCDC80
UniProt
23027862
details
GCNT1
LAP3
UniProt
23027862
details
GCNT1
HSPA14
UniProt
23027862
details
GCNT1
STMN2
UniProt
23027862
details
GCNT1
SEC24D
UniProt
23027862
details
GCNT1
PARVA
UniProt
23027862
details
GCNT1
CLTC
UniProt
23027862
details
GCNT1
PRKCB
HPRD
12765965
details
GCNT1
SCGB2A2
BioGRID, IntAct
28514442
details
GCNT1
ISLR
BioGRID, IntAct
26186194
28514442
details
GCNT1
PTCH1
BioGRID, IntAct
26186194
28514442
details
GCNT1
SLC25A46
BioGRID, IntAct
28514442
details
GCNT1
TTC19
BioGRID, IntAct
28514442
details
GCNT1
LRP1
BioGRID, IntAct
28514442
details
GCNT1
UBA52
BioGRID, IntAct
28514442
details
GCNT1
CTBP2
BioGRID
30585266
details
GCNT1
DDX58
BioGRID
32513696
details
This website requires cookies in order to function. By using the site you are agreeing to this as outlined in our
Terms of Use
I Agree